What can the QBSafe trial teach us about person-centered diabetes care? Explore its findings on A1C, medication adherence, and patient priorities.
Read More »The SGLT2 Hemoglobin Effect: A Clue to Cardiorenal Protection?
Learn how SGLT2 inhibitors affect hemoglobin and hematocrit, and what a JAMA meta-analysis reveals about possible heart and kidney benefits.
Read More »When Antibiotics Aren’t Enough: Phage Therapy Takes on Diabetic Foot Infections
Discover how BX211 bacteriophage therapy may improve diabetic foot ulcer healing, what Phase 2 trial results reveal, and why further research is needed.
Read More »Metformin Before the ICU: A Surprising Kidney Signal Challenges the Usual Narrative
A new ICU study links prior metformin use to lower odds of acute kidney injury. Explore the findings, limitations, and implications for diabetes care.
Read More »The Symptoms Were There: Why Was Type 1 Diabetes Still Missed?
Discover why type 1 diabetes symptoms are often missed in children, how diagnostic delays increase DKA risk, and what clinicians can do to improve detection.
Read More »Shine a Light on Diabetic Nerve Pain? A Sham-Controlled Trial Tests the Idea
Can laser therapy relieve diabetic neuropathy pain? Explore new clinical trial findings, treatment benefits, limitations, and what patients should know.
Read More »Does Every Person With Type 1 Diabetes Really Need a Foot Exam Every Year?
Discover what the OPTI-ONE study reveals about type 1 diabetes foot screening, annual exams, and whether low-risk patients need fewer visits.
Read More »One Molecular Switch, Two Organs: A New Clue to Type 2 Diabetes
Discover how CA8 may influence liver glucose production and pancreatic insulin secretion, revealing a possible new link in type 2 diabetes.
Read More »Good Care, Bigger Bills: The Hidden Cost of High-Deductible Diabetes Plans
Learn why high-deductible health plans increase out-of-pocket costs for diabetes care and what these expenses mean for patients and providers.
Read More »A New DME Drug Matched Anti-VEGF on Vision: Could Retina Care Be Ready for a New Option?
Discover how remigromig performed against anti-VEGF therapy in the BRUNELLO trial and what AAO 2026 findings mean for diabetic macular edema care.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.